News
Category
-
PR Newswire
Capital Rx Ranks in the Top 50 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies for the Second Year in a Row
February 28, 2023 -
Business Wire
Third Annual Science2Startup (S2S)™ Symposium on May 3, 2023 Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors
February 28, 2023 -
Globenewswire
Orchard Therapeutics Announces Agreement Enabling Reimbursed Access to Libmeldy for All Eligible MLD Patients in Sweden
February 27, 2023 -
PR Newswire
Innovent Announces First Participant Dosed in Phase 1 Clinical Study of IBI333 (VEGF-A/VEGF-C Bispecific Fusion Protein) in Patients with Neovascular Age-related Macular Degeneration
February 27, 2023 -
Business Wire
EyePoint and Rallybio Announce Research Collaboration to Evaluate Rallybio’s Inhibitor of Complement Component 5 (C5) and EyePoint’s Proprietary Durasert® Technology for Sustained Intraocular Delivery in Geographic Atrophy
February 27, 2023 -
Business Wire
Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO
February 21, 2023 -
Fast Company
This startup just raised more than half a billion dollars to change how new drugs get discovered
February 19, 2023 -
Fierce Pharma
Apellis wins FDA approval for first geographic atrophy drug
February 17, 2023 -
Globenewswire
Denali Therapeutics Announces Presentations on Enzyme Transport Vehicle (ETV) Development Programs for MPS Diseases at the Upcoming WORLDSymposium™
February 15, 2023 -
Fierce Biotech
New biotech VC takes off with $520M and a flight deck stacked with big-name investors ready to serve
February 14, 2023 -
The Guardian
Girl with deadly inherited condition is cured with gene therapy on NHS
February 14, 2023 -
Precision Oncology News
Owkin-led Machine Learning Study IDs Possible Cancer Treatment Biomarkers Using Federated Model
February 14, 2023 -
Globenewswire
Verve Therapeutics Announces VERVE-101 Awarded Innovation Passport by the UK MHRA for the Treatment of Heterozygous Familial Hypercholesterolemia
February 14, 2023 -
PR Newswire
Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy
February 14, 2023 -
Globenewswire
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
February 13, 2023 -
PR Newswire
Capital Rx Earns Surescripts® Certification & SOC 2 Type 2 Report
February 10, 2023 -
Business Wire
Ensoma Announces Closing of Twelve Bio Acquisition
February 9, 2023 -
Endpoints News
The top 100 venture investors in biopharma today. Who’s staying at the deals table?
February 9, 2023 -
GlobeNewswire
Protenus is Top Performing Solution in Two Segments Based on 2023 Best in KLAS Report
February 8, 2023 -
GlobeNewswire
Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis
February 8, 2023 -
Axios
Exclusive: Blackstone, Carlyle-backed Canoe raises $25M
February 8, 2023 -
GlobeNewswire
Structure Therapeutics Announces Pricing of Upsized Initial Public Offering
February 2, 2023 -
The White House
The White House highlights Owkin and CancerLinQ collaboration as part of its Cancer Moonshot
February 2, 2023 -
Globenewswire
Denali Therapeutics Announces New Interim Data from DNL310 Phase 1/2 Study for MPS II and DNL126 Preclinical Data for MPS IIIA at WORLDSymposium™
February 2, 2023 -
PR Newswire
Capital Rx is Honored to be Named to the 2023 New York Digital Health 100
February 1, 2023 -
GlobeNewswire
Insilico Medicine Opens Largest AI-Powered Biotechnology Research Center in the Middle East
February 1, 2023 -
Business Wire
NOCD Completes Additional Funding in its Quest to End the OCD Crisis
January 31, 2023 -
GlobeNewswire
BenchSci Announces Launch of ASCEND™ – a First-of-its-Kind ‘Map’ of All Disease Biology that Aims to Transform Pharmaceutical Research
January 31, 2023 -
Business Wire
Rallybio Announces Appointment of Jonathan I. Lieber as Chief Financial Officer
January 31, 2023 -
Business Standard
Enzene Biosciences raises $50 million, aims to expand into global markets
January 30, 2023 -
Paradigm
Paradigm Launches with $203 Million to Rebuild the Clinical Research Ecosystem
January 27, 2023 -
PR Newswire
Stride Health Recognized As One of Built In’s Best Places to Work in 2023
January 26, 2023 -
PR Newswire
Benchling Bolsters Commitment to Security with Type 2 SOC 2
January 26, 2023 -
GlobeNewswire
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies
January 26, 2023 -
Business Wire
Firefly Health Welcomes Former Massachusetts Lt. Governor Karyn Polito to its Advisory Council
January 25, 2023 -
PR Newswire
Carrot Fertility Exceeds National Benchmarks for Fertility Success, Publishes New, Independently Validated Outcomes Study
January 18, 2023 -
Business Wire
Structure Therapeutics Appoints Industry Leaders Eric Dobmeier and Joanne Waldstreicher to its Board of Directors
January 18, 2023 -
PR Newswire
Whatfix ISV Partnership Program Grows Rapidly, Empowering Software Providers to Deliver Better User Experience and Accelerate Customer Adoption
January 12, 2023 -
PR Newswire
Jefferson County to Use Eleos Health’s Augmented Intelligence to Give Therapists More Time to Serve Those With Mental Illness
January 12, 2023 -
GlobeNewswire
Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target
January 10, 2023 -
PR Newswire
Community Services Group Taps Eleos Health for Augmented Intelligence Support in Behavioral Healthcare
January 10, 2023 -
GlobeNewswire
Insilico Medicine launches 6th generation Intelligent Robotics Lab to further accelerate its AI-driven drug discovery
January 5, 2023 -
Business Wire
X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership
January 5, 2023 -
Business Wire
Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines
January 5, 2023 -
GlobeNewswire
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
January 5, 2023 -
PR Newswire
Innovent Announces NMPA’s Breakthrough Therapy Designation for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Previous Treated Advanced Non-small Cell Lung Cancer
January 4, 2023 -
PR Newswire
Patina announces partnerships with major national Medicare Advantage plans, significantly expanding the reach of its unique primary care experience for adults 65+ in Philadelphia region
December 15, 2022 -
Business Wire
Rallybio Announces Publication of Data Highlighting the Ability of HPA-1a-Specific Antibodies to Prevent Alloimmunization in an Authentic Mouse Model of FNAIT
December 15, 2022 -
PR Newswire
Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer
December 15, 2022 -
PR Newswire
Alternative Bio Launches with USD 15M Series Seed Financing Led by Eight Roads Ventures with F-Prime Capital and Sequoia China Seed Fund
December 14, 2022 -
EZ Newswire
Immuneel Therapeutics Presents Early Data from India for Varnimcabtagene Autoleucel at ASH Annual Meeting
December 14, 2022 -
PR Newswire
ABK Biomedical Raises USD 30M in Series C Financing
December 6, 2022 -
GlobeNewswire
Pulmocide Raises $52 Million to Fund Additional Late-Stage Development of Opelconazole
December 6, 2022 -
GlobeNewswire
Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform Trial
December 5, 2022 -
GlobeNewswire
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022
December 2, 2022 -
GlobeNewswire
Beam Therapeutics Announces FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for BEAM-201
December 2, 2022 -
Endpoints
Rallybio, AbCellera form new partnership around antibodies for rare disease
December 1, 2022 -
GlobeNewswire
Protenus CTO Michael Baglio Wins Top Healthcare Tech CTO Award
November 29, 2022 -
Business Wire
NOCD Educates Record Number of People During 2022 OCD Awareness Month
November 23, 2022 -
PR Newswire
AllHealth Network Selects Eleos Health to Deliver In-Session Automation, Reducing Clinician Burden and Improving Care
November 22, 2022 -
PR Newswire
Adela’s Co-Founder & Chief Scientific Officer to Deliver Plenary Session at American Association for Cancer Research (AACR) Special Conference on Precision Prevention, Early Detection, and Interception of Cancer
November 15, 2022 -
Fierce Healthcare
SonderMind picks up neuroscience company Total Brain to build out data-driven mental healthcare
November 15, 2022 -
PR Newswire
Centivo’s Virtual Primary Care practice receives NCQA Patient-Centered Medical Home Recognition
November 15, 2022 -
PR Newswire
Capital Rx is Crowned Winner of the Fierce Healthcare Fierce Innovation Award
November 15, 2022 -
PR Newswire
Deal Engine Raises $5.3M to Simplify Post-Booking Travel Transactions
November 15, 2022 -
PR Newswire
RareCyte® selected for the Wellcome Leap In Utero program; will utilize its rare cell liquid biopsy platform to perform breakthrough research to decrease stillbirth rates worldwide
November 14, 2022 -
News wise
RareCyte® selected for the Wellcome Leap In Utero program; will utilize its rare cell liquid biopsy platform to perform breakthrough research to decrease stillbirth rates worldwide
November 14, 2022 -
GlobeNewswire
Denali Therapeutics Announces Phase 1/2 Study Single Dose Healthy Volunteer Data with TAK-594/DNL593 (PTV:PGRN) and Progression to Enrolling Participants with FTD-GRN
November 1, 2022 -
Business Wire
Turnstone Biologics Announces FDA Clearance of IND for TIDAL-01, a Next-Generation TIL Therapy for Solid Tumors
October 31, 2022 -
GlobeNewswire
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022 -
PR Newswire
Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 (Recombinant anti-Claudin18.2 Monoclonal Antibody-drug Conjugate) in Patients with Advanced Solid Tumors
October 30, 2022 -
Business Wire
ConnexPay Secures $110 Million Growth Investment Led by FTV Capital to Propel Global Expansion and Unify Payments Ecosystem
October 25, 2022 -
GlobeNewswire
Prime Medicine Announces Closing of Upsized Initial Public Offering
October 24, 2022 -
Business Wire
Devoted Health Achieves Top 5 out of 5 Medicare Advantage Star Rating for Ohio HMO Plans in First Year of Eligibility
October 11, 2022 -
GlobeNewswire
BrainsWay and NOCD Launch Collaboration to Increase Awareness of OCD Treatments
October 11, 2022 -
Fierce Pharma
Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug, but commercial value uncertain
October 10, 2022 -
PR Newswire
AppliedVR Wins Q3 2022 Comparably Awards-recognized for Happiest Employees, Best Company Compensation, Best Work-Life Balance and Best Perks & Benefits
October 10, 2022 -
PR Newswire
The China NMPA Approved CYRAMZA® (ramucirumab) for the Treatment in Patients with Hepatocellular Carcinoma
October 9, 2022 -
PR Newswire
OSF HealthCare Partnering with US HealthVest on new behavioral health hospital
October 6, 2022 -
PR Newswire
New Mental Health Company Led by Consumer Brand Industry Veterans to Revolutionize Mental Health Care Delivery for Seniors
September 28, 2022 -
Business Wire
Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
September 28, 2022 -
PR Newswire
Elucidata Raises $16 Million Series A to Reimagine AI Infrastructure for the Life Sciences Industry
September 27, 2022 -
MedCity News
Prime Medicine spells out IPO plans for ‘word processor’ of gene editing
September 23, 2022 -
PR Newswire
NodThera Announces Positive Phase 1 Study Readouts for the NLRP3 Inflammasome Inhibitors NT-0796 and NT-0249
September 21, 2022 -
GlobeNewswire
Beam Therapeutics Presents First In Vivo Data Demonstrating Potential of Multiplex Base Editing Approach to Target Disease Drivers of Chronic Hepatitis B Infection
September 19, 2022 -
GlobeNewswire
RIGImmune Announces Acquisition of Antiviral Company Subintro and Concurrent Financing by F-Prime Capital
September 15, 2022 -
MobiHealthNews
Provider search firm Kyruus buys patient engagement company Epion Health
September 15, 2022 -
Fierce Biotech
AviadoBio selected by Fierce Biotech as a ‘Fierce 15’ 2022 winner
September 12, 2022 -
Business Wire
Artemis Health and Zerigo Health Announce Partnership to Help Employers and Health Plans Better Evaluate and Manage Chronic Autoimmune Skin Conditions
September 8, 2022 -
PR Newswire
Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development
September 7, 2022